Literature DB >> 24720680

Treating hepatitis C in lower-income countries.

Channa R Jayasekera1, Michele Barry, Lewis R Roberts, Mindie H Nguyen.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24720680     DOI： 10.1056/NEJMp1400160

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  40 in total

1.  Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.

Authors:  Sunil Suhas Solomon; Shruti H Mehta; Aylur K Srikrishnan; Suniti Solomon; Allison M McFall; Oliver Laeyendecker; David D Celentano; Syed H Iqbal; Santhanam Anand; Canjeevaram K Vasudevan; Shanmugam Saravanan; Gregory M Lucas; Muniratnam S Kumar; Mark S Sulkowski; Thomas C Quinn
Journal:  Lancet Infect Dis       Date:  2014-12-03       Impact factor: 25.071

2.  Future of therapy for Hepatitis C in India: A Matter of Accessibility and Affordability?

Authors:  Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-06

Review 3.  Potential Liver Transplant Recipients with Hepatitis C: Should They Be Treated Before or After Transplantation?

Authors:  Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2017-02-06

4.  Emerging Trends in Clinical Research: With Implications for Population Health and Health Policy.

Authors:  Benjamin Chin-Yee; S V Subramanian; Amol A Verma; Andreas Laupacis; Fahad Razak
Journal:  Milbank Q       Date:  2018-06       Impact factor: 4.911

5.  Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling.

Authors:  Abigail Jarret; Adelle P McFarland; Stacy M Horner; Alison Kell; Johannes Schwerk; MeeAe Hong; Samantha Badil; Rochelle C Joslyn; Darren P Baker; Mary Carrington; Curt H Hagedorn; Michael Gale; Ram Savan
Journal:  Nat Med       Date:  2016-11-14       Impact factor: 53.440

6.  Therapy of hepatitis C--back to the future.

Authors:  T Jake Liang; Marc G Ghany
Journal:  N Engl J Med       Date:  2014-05-04       Impact factor: 91.245

Review 7.  Viral hepatitis and human immunodeficiency virus co-infections in Asia.

Authors:  Takako Utsumi; Maria I Lusida
Journal:  World J Virol       Date:  2015-05-12

Review 8.  Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis.

Authors:  E Cariani; L Roli; G Missale; E Villa; C Ferrari; T Trenti
Journal:  Pharmacogenomics J       Date:  2015-04-28       Impact factor: 3.550

9.  Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients.

Authors:  Dong Ji; Guo-Feng Chen; Cheng Wang; Yu-Dong Wang; Qing Shao; Bing Li; Jun Zhao; Shao-Li You; Jin-Hua Hu; Jia-Liang Liu; Xiao-Xia Niu; Jing Chen; Lei Lu; Vanessa Wu; George Lau
Journal:  Hepatol Int       Date:  2016-07-21       Impact factor: 6.047

Review 10.  Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.

Authors:  Meredith E Clement; Lauren F Collins; Julius M Wilder; Michael Mugavero; Taryn Barker; Susanna Naggie
Journal:  Infect Dis Clin North Am       Date:  2018-06       Impact factor: 5.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.